+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Artificial Pancreas Device System Market 2019-2025

  • ID: 4896930
  • Report
  • November 2019
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Admetsys Corp.
  • Beta-O2 Technologies Ltd.
  • Companion Medical Inc.
  • Dexcom Inc.
  • Inreda Diabetic BV
  • Medtronic PLC
  • MORE
The global artificial pancreas device system market is estimated to grow impressively at a CAGR of 55% over the forecast period. Continuous glucose monitoring (CGM) system and insulin infusion pumps are the primary components of an artificial pancreas device system. Medtronic, Johnson & Johnson and Dexcom are the key market players working on the development of the artificial pancreas. Medtronic and Animas (J&J) have been successful in developing the first closed-loop system. As of November 2019, the artificial pancreas device systems are under development phase only and has not been commercialized in the market. The increasing prevalence of diabetes and its burden coupled with the rising need for advanced and innovative diabetic care devices is acting as a driving factor for the growth of the market.

Moreover, increasing awareness among the population towards diabetes and the growing focus of organizations towards the efficacy and R&D of artificial pancreas device systems across the globe is also augmenting the market growth. The global artificial pancreas device system market is segmented on the basis of type and region. On the basis of type, the market is sub-segmented into a threshold suspended device system, insulin-only system, and bi-hormonal control system. The threshold suspended device system serves as a potential back-up when a patient is unable to respond to low blood sugar (hypoglycemia) event. Owing to this, the threshold suspended device system segment is poised to hold significant potential during the forecast period.

Geographically, the market is analyzed into North America, Europe, Asia-Pacific, and the Rest of the World. North America held the dominating position in the global artificial pancreas device system market in 2018 and is further estimated to follow the same trend over the forecast period. The growth of the region is primarily backed by an increased focus on the development of the artificial pancreas system by the market players. Furthermore, the global artificial pancreas device system market is influenced by the presence of several players including Medtronic PLC, Johnson & Johnson Services Inc., Insulet Corp., Pancreum Inc., Tandem Diabetes Care Inc., and many others. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

Research Methodology

The market study of the global artificial pancreas device system market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for artificial pancreas device system manufacturers, research organizations, medical device manufacturing companies, hospitals, diagnostic centers, market research firms, and government organizations, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Artificial pancreas device system Market Research and Analysis by Type

The Report covers:
  • Comprehensive research methodology of the global artificial pancreas device system market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global artificial pancreas device system market.
  • Insights about market determinants which are stimulating the global artificial pancreas device system market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Admetsys Corp.
  • Beta-O2 Technologies Ltd.
  • Companion Medical Inc.
  • Dexcom Inc.
  • Inreda Diabetic BV
  • Medtronic PLC
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Medtronic PLC
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Johnson & Johnson Services Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Insulet Corp.
3.3.3.1. Overview
3.3.3.2. SWOT Analysis
3.3.3.3. Recent Developments
3.3.4. Pancreum, Inc.
3.3.4.1. Overview
3.3.4.2. SWOT Analysis
3.3.4.3. Recent Developments
3.3.5. Tandem Diabetes Care, Inc.
3.3.5.1. Overview
3.3.5.2. SWOT Analysis
3.3.5.3. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Artificial Pancreas Device System Market by Type
5.1.1. Threshold Suspended Device System
5.1.2. Insulin-Only System
5.1.3. Bi-Hormonal Control System

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Admetsys Corp.
7.2. Beta Bionics
7.3. Beta-O2 Technologies Ltd.
7.4. Bigfoot Biomedical Inc.
7.5. Companion Medical Inc.
7.6. Defymed SAS
7.7. Dexcom Inc.
7.8. Eli Lilly and Co.
7.9. Inreda Diabetic BV
7.10. Insulet Corp.
7.11. Johnson & Johnson Services Inc.
7.12. Medtronic PLC
7.13. Pancreum, Inc.
7.14. Tandem Diabetes Care, Inc.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Admetsys Corp.
  • Beta Bionics
  • Beta-O2 Technologies Ltd.
  • Bigfoot Biomedical Inc.
  • Companion Medical Inc.
  • Defymed SAS
  • Dexcom Inc.
  • Eli Lilly and Co.
  • Inreda Diabetic BV
  • Insulet Corp.
  • Johnson & Johnson Services Inc.
  • Medtronic PLC
  • Pancreum, Inc.
  • Tandem Diabetes Care, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll